Clinical Trial: To Evaluate the Adhesion of TK-254RX on Healthy Participants

U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07307794) titled 'To Evaluate the Adhesion of TK-254RX on Healthy Participants' on Dec. 15.

Brief Summary: This study is a single-center, open-label, multiple-dose trial in healthy participants. The primary purpose of this study is to assess the adhesion of TK-254RX. Secondary purposes are to assess the safety of TK-254RX and the residual amount of the patch.

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Esflurbiprofen Topical System

The total of one TK-254RX per day for 3 days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Teikoku Seiyaku Co., Ltd.

Published by HT Digital Conte...